FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Anesthetic topics
Anesthetic
Anesthesia
Anesthetics
Pharmaceutically Acceptable Salt
Drug Delivery System
Local Anesthesia
Phase Shift
Phase Change Material
Evaporation
Motor Function
Acute Pain
Ultrasound
Physiological Conditions
Physiologic
Cosmetic Procedure

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Anesthetic patents



      
           
This page is updated frequently with new Anesthetic-related patent applications. Subscribe to the Anesthetic RSS feed to automatically get the update: related Anesthetic RSS feeds. RSS updates for this page: Anesthetic RSS RSS


Anesthesia applicators/injectors for dental and other applications and methods of use

Anesthesia applicators/injectors for dental and other applications and methods of use

Date/App# patent app List of recent Anesthetic-related patents
01/29/15
20150027439
 Anesthetic vaporizer patent thumbnailnew patent Anesthetic vaporizer
Disclosed herein is an anesthetic vaporizer comprising a refrigeration system configured to cool a liquid anesthetic to less than 0° c. And to the anesthetic's temperature of minimal alveolar concentration.
Oregon Health And Science University
01/22/15
20150025152
 Formulation and  use of a treatment for shingles pain patent thumbnailFormulation and use of a treatment for shingles pain
A pharmaceutical formulation for treatment of shingles is provided. The formulation includes between 0.2 mg of menthol per 120 ml of the formulation and 1.0 mg of menthol per 120 ml of the formulation, camphor water, lime water, and a local anesthetic.
01/15/15
20150018801
 Anesthesia applicators/injectors for dental and other applications and methods of use patent thumbnailAnesthesia applicators/injectors for dental and other applications and methods of use
Disclosed are applicators and methods injecting of a liquid anesthetic into a dental patient with no or minimal pain. In accordance with one embodiment the applicator is for intraligamentary injection and includes an elongated, thin member having an open distal free formed of a resilient and somewhat conformable material suitable for producing a substantially fluid-tight interface with the anatomic structures at the gingival sulcus to inject the anesthetic therein.
01/15/15
20150018390
 Methods and compositions for treating post-operative pain comprising a local anesthetic patent thumbnailMethods and compositions for treating post-operative pain comprising a local anesthetic
The present invention is directed to an implantable drug depot useful for reducing, preventing or treating post-operative pain in a patient in need of such treatment, the implantable drug depot comprising a polymer and a therapeutically effective amount of a local anesthetic or pharmaceutically acceptable salt thereof, wherein the drug depot is implantable at a site beneath the skin to reduce, prevent or treat post-operative pain, and the drug depot is capable of releasing (i) a bolus dose of the local anesthetic or pharmaceutically acceptable salt thereof at a site beneath the skin and (ii) a sustained release dose of an effective amount of the local anesthetic or pharmaceutically acceptable salt thereof over a period of at least 4 days.. .
Medtronic, Inc.
01/15/15
20150018387
 High concentration local anesthetic formulations patent thumbnailHigh concentration local anesthetic formulations
A transdermal topical anesthetic formulation, which can be used to ameliorate or inhibit neuropathic pain, has been developed. In the preferred embodiment, the topical anesthetic is a local anesthetic such as lidocaine, most preferably lidocaine free-base in a gel, and the dosage of the local anesthetic is effective in the painful area or immediately adjacent areas, to ameliorate or eliminate the pain.
Centrexion I, Inc.
01/15/15
20150014211
 Medical kits patent thumbnailMedical kits
Provided is a medical kit with all the necessary components for a medical practitioner in the office practice setting to inject a variety of anesthetics. The kits can comprise a holder, such as a box, and active pharmaceutical ingredients (api), with each api placed in a separate container in a form that is ready for injection, the api selected from the group consisting of: a.
Asclemed Usa, Inc. Dba Enovachem Manufacturing
01/08/15
20150011973
 Devices, systems, and methods for medicament delivery patent thumbnailDevices, systems, and methods for medicament delivery
Certain exemplary embodiments comprise can comprise an auto-injector, which can comprise: a vial configured to store and/or contain an injectable medicament, the vial defining a vial longitudinal axis, and a housing comprising the vial. In various embodiments, the injectable medicament can be a medicine, medication, drug, pharmaceutical, prescriptive, agent, antidote, anti-venom, hormone, stimulant, vasodilator, anesthetic, and/or nutritional supplement that is substantially ready for injection..
Kaleo, Inc.
01/08/15
20150011968
 Detecting depth of anesthesia via pupil metrics patent thumbnailDetecting depth of anesthesia via pupil metrics
A video feed of one or more pupils of a patient can be received and processed to determine a raw measure of pupil size of the one or more pupils over time. Based on this raw measure, at least one of a) a depth of anesthesia for the patient, b) an index of cognitive activity for the patient, and c) a degree of perfusion of an anesthetic being administered to the patient to one or both hemispheres of a brain of the patient can be determined such that one or more actions can be caused to be performed.
Eye Tracking Inc.
01/08/15
20150011638
 Alprostadil and lidocaine treatment of premature ejaculation patent thumbnailAlprostadil and lidocaine treatment of premature ejaculation
Compositions and methods for the treatment of premature ejaculation are provided wherein a composition comprising a topical anesthetic, a shear-thinning polymeric thickener, a lipophilic component that is selected from the group consisting of an aliphatic c1 to c8 alcohol, an aliphatic c8 to c30 ester, a liquid polyol and a mixture thereof, water and a buffer system that provides a buffered ph value for the composition in the range of about 3 to about 7.4 is administered to the penile meatus.. .
Nexmed Holdings, Inc.
01/08/15
20150011587
 Alprostadil for treatment of premature ejaculation patent thumbnailAlprostadil for treatment of premature ejaculation
Compositions and methods for the treatment of premature ejaculation are provided wherein a composition comprising a topical anesthetic, a shear-thinning polymeric thickener, a lipophilic component that is selected from the group consisting of an aliphatic c1 to c8 alcohol, an aliphatic c8 to c30 ester, a liquid polyol and a mixture thereof, water and a buffer system that provides a buffered ph value for the composition in the range of about 3 to about 7.4 is administered to the penile meatus.. .
Nexmed Holdings, Inc.
01/08/15
20150011585

Alprostadil and dyclonine for treatment of premature ejaculation


Compositions and methods for the treatment of premature ejaculation are provided wherein a composition comprising a topical anesthetic, a shear-thinning polymeric thickener, a lipophilic component that is selected from the group consisting of an aliphatic c1 to c8 alcohol, an aliphatic c8 to c30 ester, a liquid polyol and a mixture thereof, water and a buffer system that provides a buffered ph value for the composition in the range of about 3 to about 7.4 is administered to the penile meatus.. .
Nexmed Holdings, Inc.
01/08/15
20150010528

Anesthetic composition, formulation and use


An anesthetic composition for use e.g. In the administration of a local anesthetic by injection comprises a first component, which comprises hyaluronidase, and a second component which comprises an anesthetic preparation.
01/01/15
20150004262

Anesthetic and therapeutic composition for use in aquaculture


An anesthetic and therapeutic composition for use in aquaculture includes an essential oil preferably thyme oil that is mixed with ethanol in an amount of one part essential oil preferably thyme oil to five parts ethanol. The essential oil ethanol mixture is then dispersed in water preferably seawater to provide 10 to 60 ppm of essential oil.
Kuwait Institute For Scientific Research
12/25/14
20140377211

In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers


An in situ film-forming sprayable methyl acetate-based solution of at least one absorbable, low-crystallinity, segmented copolymer contains at least one bioactive agent, which exhibits antimicrobial, anti-inflammatory, antiviral, anesthetic, hemostatic, and/or antineoplastic activity. The absorbable polymers can be a polyaxial copolyester, polyether-ester and polyether-ester urethane and the bioactive solution thereof can be applied onto animal and human skin or accessible body cavities to prevent or treat one or more disorder susceptible to the bioactive agent therein..
Poly-med, Inc.
12/18/14
20140371542

System and pain reduction skin puncture and breakable tip therefor


An instrument, article and method are provided for minimizing pain during administration by injection of a liquid, such as, an anesthetic. The instrument has a forward end.
Bing Innovations Llc
12/18/14
20140370124

Multi-purpose anti-itch treatment


There is disclosed a formulation of a transdermal skin treatment effective in inhibition of itch sensation. In an embodiment, the formulation includes a solvent mixture of alcohols, glycols and water combined to provide a solubility parameter between 20 pa0.5 and 40 pa0.5, the solvent mixture having an average normal boiling temperature of at least 100° c., the solvent mixture having at least 0.04 mols/liter of multivalent cations, the solvent mixture containing at least one local anesthetic, and the solvent mixture having ph exceeding 8.0, with a thixotropic flow characteristic accomplished by an organic gellant.
Satispharma, Llc
12/11/14
20140363391

System and administering poloxamers and anesthetics while performing cpr and minimizing reperfusion injury


According to an embodiment, a system for delivering a synthetic surfactant and an anesthetic to an individual to reduce reperfusion injury includes an anesthetic delivery device and a device for administering the synthetic surfactant intravenously or intraosseously. The anesthetic delivery device includes a patient connection mechanism for coupling with an airway of the individual, an intrathoracic pressure regulation (ipr) mechanism that involves changing the pressure in the airway that is coupled with the patient connection mechanism, and an anesthetic delivery mechanism for receiving the anesthetic and for delivering the anesthetic to the individual via the patient connection mechanism..
12/11/14
20140360894

Carpule to store lower dosage amount of dental anesthetic


A carpule to store lower dosage amount of dental anesthetic solution includes a tubular extrusion, a stopper, a front cap, and a color-coded band. The front cap is connected with a front opening of the tubular extrusion while the stopper is slidably engaged with a rear opening of the tubular extrusion.
12/11/14
20140360494

Combined laryngo-tracheal anesthetic and stylet device


A laryngo-tracheal anesthetic device is provided, said device comprising a malleable conduit with a first end and a second end, wherein the second end is designed to enter a patient, a device for pressurizing anesthetic, wherein the device is adapted to receive a cartridge of anesthetic, a substrate actuated by a finger of a user for releasing anesthetic from the reservoir into the malleable tube; and a nozzle at the second end of the malleable tube.. .
12/04/14
20140357686

Method of treating disease by auricular anesthesia of cranial nerves


Methods for treating a variety of diseases that comprises performing auricular anesthesia of the vagus, facial, trigeminal, or glossopharyngeal nerves, or combinations thereof. A pharmaceutical composition is administered to an ear canal of a subject in need of such treatment, the composition including an analgesic and an anesthetic.
12/04/14
20140352693

Anesthetic breathing apparatus with target value control of anesthetic agent


An anesthetic breathing apparatus has a processing unit, a breathing circuit for providing an inspiratory patient gas mixture of re-breathed gas and/or fresh gas to a patient fluidly connected to the breathing circuit, and a fresh gas supply controllable by the processing unit for supplying a flow of the fresh gas to the breathing circuit in a composition including oxygen and at least one anesthetic agent (aa). A user interface includes a first user input element for receiving operator input for an anesthetic target value including an end expiratory concentration of the aa (etaa) target value and/or an end expiratory minimum alveolar concentration (etmac) target value of an end expiratory mac value of the patient, and a second user input element for receiving operator input for a desired control profile for the fresh gas supply for obtaining at least the anesthetic target value.
11/27/14
20140350576

Apparatus and fascial closure device for laparoscopic trocar port site and surgery


A suture placement device is inserted into an endoscopic trocar port site. A pivot bar with a pair of receptor ports is moved from a folded to an extended position below the fascia.
11/20/14
20140342318

Device and treating oral pigmentation


A method is disclosed. The method discloses applying an anesthetic to at least a portion of a surface of an area in a patient's mouth affected by a gingiva pigmentation, and applying a pressurized fluid to the at least the portion of the surface..
11/13/14
20140335206

Topical analgesic composition


This invention concerns a synergistic combination of a topical anesthetic and wound barrier forming agent capable of providing extended analgesia of ‘significant open wounds’ (that being, for example, a laceration, surgical incision, abrasion, ulcer or burn, but not being a minor cut, scratch, sting, burn or abrasion) in which conventional management alternatives (such as suturing and/or administration of injected or systemic analgesia) are impractical, unaffordable or otherwise unavailable.. .
11/06/14
20140328776

Film forming personal care compositions and methods


Compositions, kits and methods of preparing a biocompatible film for cosmetic or medical uses are disclosed. The compositions or kits contain polyvinyl acetal (pva), siloxane and a solvent.
11/06/14
20140326048

System and monitoring composition in a sidestream system using a disposable sampling chamber


A system and method are configured to monitor composition of a flow of breathable gas being provided to a subject. A measurement flow of breathable gas is diverted in order to monitor composition of the flow of breathable gas, and then the measurement flow of breathable gas is returned to the flow of breathable gas.
10/30/14
20140323898

System and monitoring level of dexmedatomidine-induced sedation


A system and method for monitoring a patient experiencing an administration of at least one anesthetic drug. In certain embodiments, the method includes arranging sensors configured to acquire physiological data from a patient and reviewing the physiological data from the sensors and an indication received from an input.
10/23/14
20140316376

Method and device for painless injection of medication


A method for providing a substantially painless injection of medication into a patient, including inserting an injection needle having an outside diameter greater than 0.20 mm and less than about 0.38 mm, and injecting a medicament through the needle and into the patient at a substantially constant volumetric flow rate of about 0.05 μl/s to about 50 μl/s that provides a painless injection. The method does not require the use of an anesthetic or that the medical personnel to spend a substantial amount of time performing the injection procedure, is relatively simple and inexpensive to perform and operate, and provides a relatively high degree of safety for both the medical personnel and for the patient..
10/23/14
20140316328

Continuous anesthesia nerve conduction apparatus, system and method thereof


The invention generally relates to a continuous anesthesia nerve conduction apparatus and method thereof, and more particularly to a method and system for use in administering a continuous flow or intermittent bolus of anesthetic agent to facilitate a continuous or prolonged nerve block. In one embodiment, the apparatus includes a sheath having a proximal end, a distal end and at least one lumen extending from the proximal end to the distal end.
10/23/14
20140316327

Continuous anesthesia nerve conduction apparatus, system and method thereof


The invention generally relates to a continuous anesthesia nerve conduction apparatus and method thereof, and more particularly to a method and system for use in administering a continuous flow or intermittent bolus of anesthetic agent to facilitate a continuous or prolonged nerve block. In one embodiment, the apparatus includes a sheath having a proximal end, a distal end and at least one lumen extending from the proximal end to the distal end.
10/23/14
20140316225

System and detecting vascular contamination by surgical anesthetic using non-invasive ir spectrophotometry


A system and method for detecting vascular contamination by surgical anesthetic using non-invasive ir spectrophotometry. One embodiment is a method for operating an instrument such as an enhanced pulse oximeter to monitor a patient receiving local anesthetic marked with dye that absorbs infrared light.
10/23/14
20140316217

System and monitoring anesthesia and sedation using measures of brain coherence and synchrony


A system and method for monitoring and controlling the administration of at least one drug having anesthetic properties are provided. In certain embodiments, the method includes assembling physiological data, obtained from a plurality of sensors placed on a subject, into sets of time-series data, separating, from the sets of time-series data, a plurality of low frequency signals, and determining, from the plurality of low frequency signals, at least one of coherence information and synchrony information.
10/16/14
20140309443

Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same


The present disclosure is generally directed to neuroactive 17(20)-z-vinylcyano-substituted compound of formula (i) and (ii), as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to gaba function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds..
10/02/14
20140296936

Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods


Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods are disclosed. A representative method in accordance with an embodiment of the disclosure includes creating a therapeutic effect and a sensation in a patient by delivering to the patient first pulses having a first set of first signal delivery parameters and second pulses having a second set of second signal delivery parameters, wherein a first value of at least one first parameter of the first set is different than a second value of a corresponding second parameter of the second set, and wherein the first pulses, the second pulses or both the first and second pulses are delivered to the patient's spinal cord..
10/02/14
20140296877

Device for removing acrochordons


The invention relates to a device for removal of bothersome acrochordons or skin tags from the skin. The device has an adhesive surface which allows manipulation and locking of the skin tag in such a way that acrochordon ectomic strangulation can occur without anesthetic or risk for bleeding or infections.
10/02/14
20140296826

Preparation patch and safety syringe system


A safety syringe system including a safety syringe and an injection site preparation patch adapted for use with the safety syringe. The safety syringe includes a syringe body and a safety shield slidably disposed about the syringe body.
09/25/14
20140288481

Transdermal patch with non-water soluble adhesive and anesthetic


Embodiments associated with a transdermal delivery device are described. In one embodiment, a transdermal delivery device comprises material coated on one surface with a mixture of a non-water soluble adhesive and an anesthetic..
09/18/14
20140275241

Neuroactive substituted cyclopent[a]anthracenes as modulators for gaba type-a receptors


The present disclosure is generally directed to neuroactive substituted cyclopent[a]anthracenes as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to gaba function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds..
09/18/14
20140275170

Taste masking of anesthetics and analgesics


The present invention improves the bad taste of injected anesthetics and analgesics by incorporating a flavoring or cooling agent such as menthol into the parenteral composition.. .
09/11/14
20140259191

Fish anesthetic and method


This invention relates to a method of sedating, anaesthetising or euthanising an aquatic organism comprising the step of contacting said organism with linalool, a compositions, a body of water containing thereof and a method of transporting an aquatic organism.. .
09/11/14
20140256828

Stable liquid formulations of volatile gas anesthetics


A stable liquid nanoemulsion of a volatile gas anesthetic, such as, isoflurane or sevoflurane, is disclosed which is effective in inducing and maintaining a state of anesthesia and/or general anesthesia in a patent. A method of preparation of stable liquid formulations of volatile gas anesthetics is presented, as well as a method for directly testing the concentration of a volatile gas anesthetic in a stable liquid formulation.
09/11/14
20140256805

Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for gaba type-a receptors


The present disclosure is generally directed to neuroactive substituted cyclopenta[b]phenanthrenes as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to gaba function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds..
09/04/14
20140249120

Neuroactive 13, 17-substituted steroids as modulators for gaba type-a receptors


The present disclosure is generally directed to neuroactive 13,17-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to gaba function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds..
08/28/14
20140238393

Medical vaporizer and monitoring of a medical vaporizer


The present application includes an independent and redundant measurement of anesthetic concentration, based on acoustic time-of-flight measurements, added to an anesthetic vaporizer. The redundant anesthetic concentration measurement is used to make the vaporizer inherently safe by design and monitor true vaporizer empty.
08/21/14
20140235600

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same


The present disclosure is generally directed to neuroactive 19-alkoxy-17-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to gaba function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds..
08/21/14
20140234421

Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration


The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues.
08/14/14
20140224694

Propofol formulations with non-reactive container closures


A container storing an anesthetic is disclosed. The container is sealed by a closure and stores a liquid anesthetic solution.
08/14/14
20140224693

Propofol formulations with non-reactive container closures


A container storing an anesthetic is disclosed. The container is sealed by a closure and stores a liquid anesthetic solution.
08/14/14
20140224376

Methods and systems for buffering solutions with controlled tonicity


An anesthetic cartridge is adapted to receive a volume of buffer by displacing a plunger in one end of the anesthetic cartridge inwardly so that addition of the buffer volume will not displace the plunger excessively beyond the end of the cartridge body. The inwardly displaced end is protected by a plug or cover which prevents contamination and which is ejected when the buffer is added.
08/07/14
20140221918

Buffering agent delivery system for anesthetic syringe


A syringe for dispensing anesthetic from a cartridge having an interior wall defining a hollow interior sized and shaped for receiving a dose of anesthetic, and a piston. The syringe includes a tubular plunger slidably received in the hollow interior of the tubular cartridge.
07/31/14
20140213547

Hyaluronic acid-based gels including lidocaine


Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. In one aspect, hyaluronic acid-based compositions described herein include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine.
07/31/14
20140213546

Hyaluronic acid-based gels including lidocaine


Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. In one aspect, hyaluronic acid-based compositions described herein include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine.
07/24/14
20140207050

Use of local anesthesia and electrical stimulation in peripheral wound treatment


A wound therapy method that results in improved wound healing for conditions including diabetic foot ulcers, pressure ulcers, and arterial and venous ulcers is described. The wound therapy method uses local anesthetic injections in an area surrounding the wound combined with electrical stimulation causing local and deep muscle contraction in the same area.
07/24/14
20140206773

Therapeutic compounds


Wherein x is h or f; or a pharmaceutically acceptable salt or prodrug thereof, useful as an anesthetic.. .
07/24/14
20140206635

Metal-salen complex compound, local anesthetic and antineoplastic drug


A metal-salen complex compound, which exhibits excellent noninvasiveness and can be efficiently transferred to an affected site, a local anesthetic containing this metal-salen complex compound, and an antineoplastic drug containing this metal-salen complex compound are provided. Regarding the metal-salen complex compound, a metal atom part in each of two molecules of a metal-salen complex or a derivative of the metal-salen complex is dimerized via water, and the metal-salen complex compound is mixed with a base to produce an ointment..
07/24/14
20140205650

Coated suppositories


The invention relates to coating of suppositories containing free unsaturated fatty acid, fatty acid ethyl ester and fatty acid monoglyceride that are susceptible to oxidative degradation. The coating retards oxidative degradation of unsaturated fatty acids and gives the suppository a non-oily and smooth surface.
07/24/14
20140205589

New stable anesthetic composition for reducing skin reactions


A composition is described with reduced degradation rate and/or improved stability of its components. The composition can alleviate or even annihilate cutaneous reactions and can include an emulsion with an oil phase and an aqueous phase, wherein the oil phase can be a eutectic mixture of at least one anesthetic compound and at least one adrenergic receptor agonist.


Popular terms: [SEARCH]

Anesthetic topics: Anesthetic, Anesthesia, Anesthetics, Pharmaceutically Acceptable Salt, Drug Delivery System, Local Anesthesia, Phase Shift, Phase Change Material, Evaporation, Motor Function, Acute Pain, Ultrasound, Physiological Conditions, Physiologic, Cosmetic Procedure

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Anesthetic for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Anesthetic with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         





1.4816

3368

458970 - 0 - 72